Positioning of proteasome inhibitors in therapy of solid malignancies

por Roeten, Margot S. F., Cloos, Jacqueline, Jansen, Gerrit
Publicado 2017

Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication

por Hansen, Quinty, Bachas, Costa, Smit, Linda, Cloos, Jacqueline
Publicado 2022

Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia

por Zeijlemaker, Wendelien, Kelder, Angele, Cloos, Jacqueline, Schuurhuis, Gerrit Jan
Publicado 2019

Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia

por Widjajanto, Pudjo H, Sumadiono, Sumadiono, Cloos, Jacqueline, Purwanto, Ignatius, Sutaryo, Sutaryo, Veerman, Anjo JP
Publicado 2013

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis

por Zaal, Esther A., Wu, Wei, Jansen, Gerrit, Zweegman, Sonja, Cloos, Jacqueline, Berkers, Celia R.
Publicado 2017

Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol

por Supriyadi, Eddy, Veerman, Anjo J. P., Sutaryo, Purwanto, Ignatius, vd Ven, Peter M., Cloos, Jacqueline
Publicado 2012

MRD Tailored Therapy in AML: What We Have Learned So Far

por Ngai, Lok Lam, Kelder, Angèle, Janssen, Jeroen J. W. M., Ossenkoppele, Gert J., Cloos, Jacqueline
Publicado 2021

AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML

por Hanekamp, Diana, Tettero, Jesse M., Ossenkoppele, Gert J., Kelder, Angèle, Cloos, Jacqueline, Schuurhuis, Gerrit Jan
Publicado 2021

(Immuno)proteasomes as therapeutic target in acute leukemia

por Cloos, Jacqueline, Roeten, Margot SF, Franke, Niels E, van Meerloo, Johan, Zweegman, Sonja, Kaspers, Gertjan JL, Jansen, Gerrit
Publicado 2017

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

por Jansen, Gerrit, Al, Marjon, Assaraf, Yehuda G., Kammerer, Sarah, van Meerloo, Johan, Ossenkoppele, Gert J., Cloos, Jacqueline, Peters, Godefridus J.
Publicado 2023

Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma

por Mir, Shahryar E., Smits, Michiel, Biesmans, Dennis, Julsing, Machteld, Bugiani, Marianna, Aronica, Eleonora, Kaspers, Gertjan J.L., Cloos, Jacqueline, Würdinger, Thomas, Hulleman, Esther
Publicado 2017

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

por Janssen, Luca L.G., Westers, Theresia M., Rovers, Jeroen, Valk, Peter J.M., Cloos, Jacqueline, de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2023

Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation

por Sciarrillo, Rocco, Wojtuszkiewicz, Anna, Kooi, Irsan E., Leon, Leticia G., Sonneveld, Edwin, Kuiper, Roland P., Jansen, Gerrit, Giovannetti, Elisa, Kaspers, Gertjan J.L., Cloos, Jacqueline
Publicado 2020

Computational comparison of common event-based differential splicing tools: practical considerations for laboratory researchers

por Muller, Ittai B., Meijers, Stijn, Kampstra, Peter, van Dijk, Steven, van Elswijk, Michel, Lin, Marry, Wojtuszkiewicz, Anna M., Jansen, Gerrit, de Jonge, Robert, Cloos, Jacqueline
Publicado 2021

Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis

por Muller, Ittai B, Lin, Marry, Lems, Willem F, ter Wee, Marieke M, Wojtuszkiewicz, Anna, Nurmohamed, Michael T, Cloos, Jacqueline, Assaraf, Yehuda G, Jansen, Gerrit, de Jonge, Robert
Publicado 2020

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells

por Roeten, Margot S.F., van Meerloo, Johan, Kwidama, Zinia J., ter Huizen, Giovanna, Segerink, Wouter H., Zweegman, Sonja, Kaspers, Gertjan J.L., Jansen, Gerrit, Cloos, Jacqueline
Publicado 2021

Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis

por Polak, Tobias B., van Rosmalen, Joost, Dirven, Stijn, Herzig, Julia K., Cloos, Jacqueline, Meshinchi, Soheil, Döhner, Konstanze, Janssen, Jeroen J.W.M., Cucchi, David G.J.
Publicado 2022

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROU...

por Roeten, Margot, van Dijk, Suzanne, van Meerloo, Johan, Kwidama, Zinia, Jenkins, Gaya, Teachey, David, Devidas, Meenakshi, Loh, Mignon, Kaspers, Gertjan, Zweegman, Sonja, Jansen, Gerrit, Horton, Terzah, Cloos, Jacqueline
Publicado 2023

Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML

por Wojtuszkiewicz, Anna, van der Werf, Inge, Hutter, Stephan, Walter, Wencke, Baer, Constance, Kern, Wolfgang, Janssen, Jeroen J. W. M., Ossenkoppele, Gert J., Haferlach, Claudia, Cloos, Jacqueline, Haferlach, Torsten
Publicado 2021

Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines

por Niewerth, Denise, Kaspers, Gertjan JL, Assaraf, Yehuda G, van Meerloo, Johan, Kirk, Christopher J, Anderl, Janet, Blank, Jonathan L, van de Ven, Peter M, Zweegman, Sonja, Jansen, Gerrit, Cloos, Jacqueline
Publicado 2014